Table 1.
Family | Virus | Viral IFN-antagonist involved in targeting the RLRs pathway |
||
---|---|---|---|---|
Hide | Mask | Hit | ||
Arenaviridae (OW) | LASFV | NP | NP, Z | |
Arenaviridae (NW) | JUNV | NP, Z | ||
MACV | NP, Z | |||
Bunyaviridae | CCHFV | L (?) | vOTU | |
HTNV | L (?) | Gn | ||
RVFV | NSs | |||
Coronaviridae | SARS-CoV | nsp4, N | nsp14 | ORF3b, ORF6, M, nsp3 |
Filoviridae | EBOV | VP35 | VP35 | |
MARV | VP35 | VP35 | ||
Flaviviridae | DENV | NS4A | NS3B2 | |
WNV | NS4A | NS3B2 | ||
Henipaviridae | HeV | V, W | ||
NiV | V, W | |||
Orthomyxoviridae | IAVs | NS1 | NS1, PB1, PB2, PA, PB1-F2 |
CCHFV, Crimean-Congo hemorrhagic fever virus; DENV, dengue virus; EBOV, Ebola virus; HTNV, Hantaan virus; HeV, Hendra virus; IAVs, influenza A viruses; JUNV, Junin virus; LASFV, Lassa fever virus; MACV, Machupo virus; MARV, Marburg virus; NiV, Nipah virus; RVFV, Rift Valley fever virus; SARS-CoV, severe acute respiratory syndrome coronavirus; WNV, West Nile virus.